http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102584956-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d94573ab2c57e8b193f3a22accddf9fe |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51 |
| filingDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c8bece091d32968b0608cb79efe11a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaccafd42a931433c38979218511ade1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae54a0a2d5c45ac1baa988fffef5fe86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a12b5f762388433f7e5e9100c51e7390 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_672b002764077f11051a1921e769a052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_364170efe6f167a36d785fbdf26207ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dccb50e993bfa7589a62a3db19fcd10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a282e1d92096d331575d9d5be2db812e |
| publicationDate | 2014-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102584956-B |
| titleOfInvention | Novel mutain and coding gene of related gene IFNA 2 of chronic viral hepatitis type b and application thereof |
| abstract | The invention discloses novel mutain and a coding gene of a related gene IFNA 2 of chronic viral hepatitis type b and application thereof. The novel mutain of the related gene IFNA 2 of the chronic viral hepatitis type b is formed by changing alanine at the 120 position of an amino acid sequence of related gene IFNA 2 protein of the chronic viral hepatitis type b into threonine, simultaneously, the coding gene of the mutain is obtained, and a diagnostic kit based on the IFNA 2 gene and mutant of the gene is established. The diagnostic kit can enable the diagnosis of gene levels to be performed on a chronic hepatitis patient in clinic and can guide the clinical medication condition and enable personalized treatment to be performed. From a long view, mutation detection of the IFNA 2 gene for the chronic viral hepatitis type b enables users to treat the disease through a gene treatment method of correcting mutation or a biological effect method specific to the mutation in the future and has profound significance and application prospects in the aspect of clinical treatment. |
| priorityDate | 2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.